Recently, Tempus AI TEM updated its sales guidance for 2025. It did so for the second time within six months, backed by a strong second-quarter performance. Full-year revenues are now expected to be ...

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting ...

Tempus AI achieves strong revenue growth and beats expectations, but ongoing losses and execution risks temper enthusiasm.

In a report released today, Rachel Vatnsdal from J.P. Morgan maintained a Hold rating on Tempus AI, Inc. Class A, with a price target of $60.00. The company’s shares closed last Friday at $60.87. Take ...

In a report released on August 8, Subbu Nambi from Guggenheim reiterated a Buy rating on Tempus AI, Inc. Class A, with a price target of $75.00. The company’s shares closed last Friday at $60.87.

Alphabet, UnitedHealth Group, Salesforce, Oracle, ServiceNow, Palo Alto Networks, and Tempus AI are the seven Healthcare ...

U.S. President Donald Trump launched a scathing attack on former House speaker Nancy Pelosi and her husband Paul Pelosi, on ...

The stock of Tempus AI (NASDAQ: TEM) gave back some of its gains after surging early in Friday's trading, but it still ended ...

In trading on the Nasdaq stock market as of 1:17 p.m. Central, Tempus' stock price was trading at $60.65, up 3.2% from the ...

Yahoo Finance anchor Julie Hyman tracks Friday's top moving stocks and biggest market stories in this Market Minute. Gold ...

The firm's genomics revenues more than doubled year over year, while data and services revenue increased nearly 36 percent.

Shares of Tempus AI climbed after the company narrowed its net loss and logged higher-than-expected revenue in the second quarter, boosted by what Chief Executive Eric Lefkofsky called a significant ...